000 01368 a2200349 4500
005 20250515051346.0
264 0 _c20070126
008 200701s 0 0 eng d
022 _a0022-5347
024 7 _a10.1016/j.juro.2006.08.073
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aWeiss, Robert H
245 0 0 _ap21 is a prognostic marker for renal cell carcinoma: implications for novel therapeutic approaches.
_h[electronic resource]
260 _bThe Journal of urology
_cJan 2007
300 _a63-8; discussion 68-9 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
650 0 4 _aBiomarkers, Tumor
_xanalysis
650 0 4 _aCarcinoma, Renal Cell
_xchemistry
650 0 4 _aCyclin-Dependent Kinase Inhibitor p21
_xanalysis
650 0 4 _aHumans
650 0 4 _aKidney Neoplasms
_xchemistry
650 0 4 _aPrognosis
700 1 _aBorowsky, Alexander D
700 1 _aSeligson, David
700 1 _aLin, Pei-Yin
700 1 _aDillard-Telm, Lisa
700 1 _aBelldegrun, Arie S
700 1 _aFiglin, Robert A
700 1 _aPantuck, Allan D
773 0 _tThe Journal of urology
_gvol. 177
_gno. 1
_gp. 63-8; discussion 68-9
856 4 0 _uhttps://doi.org/10.1016/j.juro.2006.08.073
_zAvailable from publisher's website
999 _c16730666
_d16730666